ANVISA Medical Device Regulation 2026: Brazil and Chile's Technical Exchange and Its Impact

Brazil's ANVISA and Chile's ISP held a technical exchange from July 6-10, 2026, to deepen regulatory cooperation. This episode explores the key topics discussed—including Brazilian GMP certification, import controls, and post-market surveillance—and analyzes the implications for medical device manufacturers. We discuss how this collaboration supports the broader trend of regulatory convergence in Latin America and what practical steps companies can take to prepare for a more harmonized market. Key Questions: - What was the purpose of the technical exchange between Brazil's ANVISA and Chile's ISP? - Which key regulatory topics were discussed between July 6-10, 2026? - How could ANVISA's GMP certification process influence requirements in Chile? - What does this collaboration signal for the future of medical device regulation in Latin America? - How might import controls and post-market surveillance policies align between the two countries? - Why is regulatory convergence in LATAM important for medical device manufacturers? - What practical steps should regulatory teams take in response to this development? Sources: - https://www.pure-global.com/thought-leadership/anvisa-brazil-chile-regulatory-cooperation-2026/ How Pure Global can help: Pure Global provides comprehensive regulatory consulting for MedTech and IVD companies seeking to access markets in Latin America and over 30 countries worldwide. Our local experts in Brazil and other key markets offer on-the-ground support, from developing regulatory strategy and compiling technical dossiers to acting as your official in-country representative. We leverage advanced AI and data tools to streamline the submission process and monitor regulatory changes, ensuring your products achieve and maintain compliance efficiently. Contact us at [email protected] or visit https://pureglobal.com to learn how we can accelerate your market entry. Explore our free AI tools and device database at https://pureglobal.ai.